Archive · 29 Jul 2026
Johnson & Johnson Settles Talc Lawsuits for $5.5 Billion
Johnson & Johnson has agreed to pay $5.5 billion to settle lawsuits from people who said their baby powder caused cancer.
The company says the powder is safe, but they agreed to the deal to end the legal fights.
The lawsuits started a long time ago, and the company stopped selling the powder in 2020.
The settlement covers almost all the cases, and both sides are happy with the deal.
Johnson & Johnson agrees to a $5.5 billion settlement for talc lawsuits.
The settlement resolves about 76,000 cases, covering 99.75% of remaining claims.
J&J denies that talc products cause cancer but agreed to the settlement.
The company stopped selling talc-based baby powder in the U.S. in 2020.
Litigation resumed in March 2025 after a three-year pause.
- Who
- Johnson & Johnson and tens of thousands of plaintiffs
- What
- Settlement of talc baby powder cancer lawsuits
- When
- July 28, 2026
- Where
- United States
- Why
- To resolve allegations that talc products cause ovarian cancer
Plaintiffs
Johnson & Johnson
Causation of Cancer
Plaintiffs
Believe talc products cause ovarian cancer and have suffered as a result.
Johnson & Johnson
Denies that talc products cause cancer, asserting they are safe and asbestos-free.
Settlement Agreement
Plaintiffs
Accepted the settlement as a resolution after a decade-long legal battle.
Johnson & Johnson
Agreed to the settlement to resolve tens of thousands of lawsuits.
- Settlement Amount
- $5.5 billion
- Number of Cases
- 76,000
- Percentage of Cases Resolved
- 99.75%
- Date of Settlement Announcement
- July 28, 2026
- Date of Product Discontinuation
- 2020
- Resumption of Litigation
- March 2025
- Expected Payment in 2027
- $3 billion
- Potential Total Payout
- Up to $7 billion
Sources
Why Johnson & Johnson agreed to pay $5.5 billion despite denying cancer claims
Johnson & Johnson agrees to $5.5 billion settlement in talc baby powder cancer lawsuits
Johnson & Johnson Ends Decade-Long Talc Cancer Battle: Here's What You Should Know About Mesothelioma
Johnson & Johnson moves to end decade-long baby powder cancer battle with £4.1bn settlement
